Optimizing Site Selection for Phase III Oncology Clinical Trial

Discover how a pharmaceutical company leveraged advanced analytics to streamline site selection for a Phase III oncology trial, ensuring efficient patient recruitment and high-quality data collection. Learn how integrating patient demographics, investigator profiles, and social determinants of health can enhance trial outcomes and accelerate drug development.

Upping the Migraine Intelligence Quotient: Real-world data sheds light on prevalence rates, providers and treatment variation

Discover groundbreaking insights into migraine prevalence, treatment variations, and healthcare provider dynamics with the PurpleLab Migraine Study. This comprehensive whitepaper leverages real-world data to illuminate the complexities of migraine management, offering valuable intelligence for healthcare providers and life sciences companies.

New Treatments Hold Significant Promise, but are Marketing Teams Helping Life Sciences Companies Deliver on this Potential?

Life sciences companies are operating in a new world, one where new treatments are being developed at breakneck speed, which holds unprecedented promise for patients. However, this new world is also one that requires the use of real world data (RWD) to empower marketing teams to effectively engage with various stakeholders – and ultimately lead healthcare providers to prescribe innovative drugs to the patients who will truly benefit from these treatment therapies.

How Deerfield Optimized Healthcare Advertising Campaigns Using Purplelab®’s Real-World Data Insights

Analyzing real-world data (RWD) in pharmaceutical marketing has the power to unearth hidden trends and insights into the overall prescription landscape. However, accessing and compiling this data tends to be a resource-intensive process. This case study explores how PurpleLab’s Prescription Measurement Report empowered the marketing agency Deerfield to harness RWD insights effectively.